Chemoinformaics analysis of Z,E-2-METHYL-3,13-OCTADECADIEN-1-OL
| Molecular Weight | 280.496 | nRot | 14 |
| Heavy Atom Molecular Weight | 244.208 | nRig | 2 |
| Exact Molecular Weight | 280.277 | nRing | 0 |
| Solubility: LogS | -6.456 | nHRing | 0 |
| Solubility: LogP | 7.243 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 56 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 20 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 36 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 19 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 56.5365 |
| nHD | 1 | BPOL | 36.1155 |
| QED | 0.304 |
| Synth | 3.015 |
| Natural Product Likeliness | 1.506 |
| NR-PPAR-gamma | 0.061 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0 |
| Pgp-sub | 0.021 |
| HIA | 0.008 |
| CACO-2 | -4.493 |
| MDCK | 0.0000119 |
| BBB | 0.181 |
| PPB | 0.98075 |
| VDSS | 4.1 |
| FU | 0.0199504 |
| CYP1A2-inh | 0.547 |
| CYP1A2-sub | 0.2 |
| CYP2c19-inh | 0.314 |
| CYP2c19-sub | 0.064 |
| CYP2c9-inh | 0.308 |
| CYP2c9-sub | 0.944 |
| CYP2d6-inh | 0.114 |
| CYP2d6-sub | 0.423 |
| CYP3a4-inh | 0.618 |
| CYP3a4-sub | 0.068 |
| CL | 5.979 |
| T12 | 0.15 |
| hERG | 0.015 |
| Ames | 0.007 |
| ROA | 0.013 |
| SkinSen | 0.95 |
| Carcinogencity | 0.047 |
| EI | 0.98 |
| Respiratory | 0.024 |
| NR-Aromatase | 0.187 |
| Antiviral | Yes |
| Prediction | 0.542834 |